Enriching for Tumor-Reactive CD8 TIL with CD39/103 Markers: Implications for TIL Therapy
Publication Title
TIL Therapies Summit
Document Type
Article
Publication Date
10-20-2021
Keywords
oregon; portland; chiles
Area of Special Interest
Cancer
Specialty/Research Institute
Earle A. Chiles Research Institute
Specialty/Research Institute
Oncology